Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | Lestaurtinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | FGF Basic | 34.0 | 51 | |
N2586 | Ruxolitinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | FGF Basic | 35.5 | 60 | |
N2586 | Tofacitinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | FGF Basic | 137.5 | 76 | |
N2586 | IKK16 | 2.0 | uM | EGF | 100 | ng/mL | 3 | FGF Basic | 20.5 | 62 | |
N2586 | JNK-IN-11 | 0.3 | uM | 3 | FGF Basic | 35.0 | 49 | ||||
RA2159 | 3 | FGF Basic | 29.5 | 60 | |||||||
RA2159 | PD184352 | 0.1 | uM | 3 | FGF Basic | 31.0 | 58 | ||||
RA2159 | Lestaurtinib | 0.3 | uM | 3 | FGF Basic | 32.0 | 53 | ||||
RA2159 | Ruxolitinib | 0.3 | uM | 3 | FGF Basic | 31.0 | 61 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 3 | FGF Basic | 31.5 | 60 | ||||
RA2159 | IKK16 | 2.0 | uM | 3 | FGF Basic | 32.0 | 53 | ||||
RA2159 | JNK-IN-8 | 3.0 | uM | 3 | FGF Basic | 30.0 | 76 | ||||
N2586 | 3 | FGF Basic | 36.5 | 76 | |||||||
N2586 | PD184352 | 0.1 | uM | 3 | FGF Basic | 30.0 | 72 | ||||
N2586 | Lestaurtinib | 0.3 | uM | 3 | FGF Basic | 33.0 | 60 | ||||
N2586 | Ruxolitinib | 0.3 | uM | 3 | FGF Basic | 35.5 | 80 | ||||
N2586 | Tofacitinib | 0.3 | uM | 3 | FGF Basic | 201.0 | 49 | ||||
N2586 | IKK16 | 2.0 | uM | 3 | FGF Basic | 36.0 | 71 | ||||
N2586 | JNK-IN-8 | 3.0 | uM | 3 | FGF Basic | 29.0 | 63 | ||||
RA2159 | IL-17A | 100 | ng/mL | 3 | FGF Basic | 33.0 | 58 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 3 | FGF Basic | 36.0 | 61 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | FGF Basic | 33.0 | 73 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | FGF Basic | 35.5 | 58 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | FGF Basic | 35.5 | 78 | |
RA2159 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 3 | FGF Basic | 33.0 | 59 |